Top

Published in:

01-03-2001 | ORIGINAL ARTICLE

The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells

Authors: Siew Yen Chong, Ming Zhang, Yi-Chu Lin, Frederick Coffman, Zenaida Garcia, Nicholas Ponzio, Elizabeth S. Raveche

Published in: Cancer Immunology, Immunotherapy | Issue 1/2001

Title: The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells
Authors: Siew Yen Chong
Ming Zhang
Yi-Chu Lin
Frederick Coffman
Zenaida Garcia
Nicholas Ponzio
Elizabeth S. Raveche
Publication date: 01-03-2001
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 1/2001
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620000165

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2001

Michael Rawling Price: an appreciation

Acknowledgement to Reviewers

A listing of human tumor antigens recognized by T cells

Effect of interferon-γ on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells

Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia

In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody

Keynote webinar | Spotlight on antibody–drug conjugates in cancer